Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Fighting Climate Change: Urban Greennes, Active Mobility and Health Co-benefits. [Phase 4]
Phase 4 trial update on urban greenness and active mobility with health co-benefits for respiratory and allergic symptoms.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Asthma and Obesity: Pilot Study [NA]
Pilot clinical trial investigating asthma and obesity has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma [Phase 4]
A Phase 4 clinical trial evaluating azithromycin for non-eosinophilic chest tightness variant asthma; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma [Phase 4]
A Phase 4 trial evaluating the effectiveness of an albuterol multidose dry powder inhaler with an integrated electronic module (eMDPI DS) in…
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma. [Phase 4]
Phase 4 trial updates the magnitude and predictors of response to omalizumab and mepolizumab in adult severe asthma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: The Effect of Cetirizine on Bronchoconstriction [Phase 4]
Phase 4 trial examining the effect of cetirizine on bronchoconstriction in patients with allergic rhinitis and asthma completed.
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma [Phase 1]
Phase 1 trial updating results for tezepelumab (AMG 157) in adults with mild asthma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma [Phase 3]
Phase 3 trial evaluating the safety and efficacy of the fluticasone furoate/vilanterol fixed-dose combination versus fluticasone furoate alo…
-
FDA approval · 2022-10-12FDA Approved: THEOPHYLLINE — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved an original application for a generic Theophylline product from Teva Pharmaceuticals.
-
FDA approval · 2022-10-11FDA Approved: ZILEUTON — Original Application (NorthStar RxLLC)
The FDA approved the original application for zileuton, with NorthStar RxLLC listed as the applicant.
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Trial of Roflumilast in Asthma Management (TRIM) [Phase 2]
A Phase 2 trial update on roflumilast for asthma management has completed, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-30Clinical Trial Update: A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) used four times daily in adult…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Budesonide/Albuterol MDI (PT027) in adults and children aged 4+ with asthma has complete…
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Pilot of Lifestyle and Asthma Intervention [NA]
A completed pilot clinical trial evaluating lifestyle and asthma intervention outcomes; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Aspirin for Uncontrolled Asthma [Phase 3]
A Phase 3 clinical trial investigated aspirin for uncontrolled asthma and has now completed.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma [Phase 2]
A Phase II clinical trial update for a drug candidate (610) in participants with severe eosinophilic asthma is ongoing, with status currentl…
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma [Phase 4]
A Phase 4 clinical trial compared single-dose efficacy of a breath-actuated albuterol inhaler with a standard albuterol MDI in participants …
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Ideal Steroids for Asthma Treatment in the PICU [Phase 4]
A Phase 4 clinical trial investigating the ideal steroids for asthma treatment in pediatric intensive care settings has completed with resul…
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients [Phase 3]
A Phase 3 randomized, placebo-controlled trial comparing budesonide/formoterol to Symbicort in asthmatic patients has been completed with re…
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Study of the Inflammation and Airway Changes That Occur After Exposure to Allergen in Asthmatics [Phase 2]
Phase 2 clinical trial investigating inflammation and airway changes after allergen exposure in individuals with asthma; completed with resu…
-
FDA approval · 2022-08-16FDA Approved: IPRATROPIUM BROMIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original ANDA for ipratropium bromide as a generic inhalation product from Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period [Phase 3]
Phase 3 trial update on as-needed budesonide/formoterol Turbuhaler for stepping down in asthma has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Promoting Risk Reduction Among Young Adults With Asthma During Wildfire Smoke Events (TRAK) [NA]
A completed clinical trial evaluating risk reduction strategies for young adults with asthma during wildfire smoke events.
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of Flamboyant 125/12 in adults with moderate asthma.
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma [Phase 3]
Phase 3 clinical trial update evaluating efficacy and safety of Flamboyant 200/12 association in adults with severe asthma.